Simultaneous human immunodeficiency virus-hepatitis B-hepatitis C point-of-care tests improve outcomes in linkage-to-care: Results of a randomized control trial in persons without healthcare coverage

Open Forum Infectious Diseases

Volumn 2, Issue 4, 2015, Pages

  Bottero, Julie ^a,b   Boyd, Anders ^a   Gozlan, Joel ^c,d   Carrat, Fabrice ^a,d   Nau, Jean ^e   Pauti, Marie Dominique ^e   Rougier, Hayette ^b   Girard, Pierre Marie ^a,b   Lacombe, Karine ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b Section of Radiology   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e République Démocratique du Congo   (France)

Author keywords

HIV; Linkage to care; Point of care rapid test; Screening; Viral hepatitis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEROLOGY;

EID: 85014273615     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv162     Document Type: Article

References (45)

1. ELPA. Report on hepatitis patient self-help in Europe. European Liver Patients Association. Available at: http://wwwhepbcppaorg/wp-content/uploads/2011/11/report-on-patient-self-helppdf. 2010. Accessed November 15, 2015.
2. Hatzakis A, Wait S, Bruix J, Buti M, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat 2011; 18:1-16.
3. Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The National Academies Press. 2010. Available at: http://www.cdc.gov/hepatitis/pdfs/iomhepatitisandlivercancerreport. pdf. Accessed November 15, 2015.
4. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat 2011; 18:377-83.
5. Yehia BR, Schranz AJ, Umscheid CA, Lo Re V. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One 2014; 9:e101554.
6. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2012. HIV Surveillance Report. 2014; 24.Available at: http://www.cdc.gov/hiv/pdf/statistics_2012_HIV_Surveillance:Report_vol_24.pdf. Accessed November 15, 2015.
7. European Centre for Disease Prevention and Control. HIV/AIDS Surveillance in Europe 2012. 2013. Available at: http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=971. Accessed November 15, 2015.
8. Holtgrave DR, Hall HI, Wehrmeyer L, Maulsby C. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success? AIDS Behav 2012; 16:1365-72.
9. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-50.
10. Coates TJ, Richter L, Caceres C. Behavioral strategies to reduce HIV transmission: how to make them work better. Lancet 2008; 372:669-84.
11. Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012; 308:370-8.
12. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507-39.
13. Sabin CA, Schwenk A, Johnson MA, et al. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010; 24:723-7.
14. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA 2014; 312:631-40.
15. Branson BM, Handsfield HH, Lampe MA, et al. Revised for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55:1-17.
16. Prazuck T, Ducasse E, Huard E, et al. Rapid tests for the diagnosis of HIV infection in free and anonymous screening consultations in France: consequences on concomitant serologies feedback and usefulness of recalling patients lost to follow-up. Bull Epidémiol Hebd 2013; 30:369-76.
17. Picard O, Valin N, Fonquernie L, et al. Rapid tests for the diagnosis of HIV infection in free and anonymous screening consultations: a pilot experience in France (January 2010-January 2011). Bull Epidemiol Hebd 2011; 42:438-41.
18. Champenois K, Le Gall JM, Jacquemin C, et al. ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men. BMJ Open 2012; 2: e000693.
19. Lorente N, Preau M, Vernay-Vaisse C, et al. Expanding access to nonmedicalized community-based rapid testing to men who have sex with men: an urgent HIV prevention intervention (the ANRS-DRAG study). PLoS One 2013; 8:e61225.
20. Ricardo-Rodrigues I, Jimenez-Garcia R, Hernandez-Barrera V, et al. Social disparities in access to breast and cervical cancer screening by women living in Spain. Public Health 2015; 129:881-8.
21. Rondet C, Soler M, Ringa V, et al. The role of a lack of social integration in never having undergone breast cancer screening: results from a population-based, representative survey in the Paris metropolitan area in 2010 Prev Med 2013; 57:386-91.
22. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010; 82:546-55.
23. Deuffic-Burban S, Deltenre P, Buti M, et al. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology 2012; 143:974-85.e14.
24. Morlat P. [Management of people leaving with HIV. 2013 report: experts recommendations]. La Documentation Française. Available at: http://www.sante.gouv.fr/IMG/pdf/Rapport_Morlat_2013_Mise_en_ligne.pdf. 2013. Accessed November 15, 2015.
25. Supervie V, Ndawinz JD, Lodi S, Costagliola D. The undiagnosed HIV epidemic in France and its implications for HIV screening strategies. AIDS 2014; 28:1797-804.
26. Daniel D, ANRS and AFEF. Management of persons with hepatitis B or hepatitis C virus infection-Report of recommendations 2014. Available at: http://www.afef.asso.fr/rc/org/afef/nws/news/2015/20150717-114851-940/src/nws_fulltext/fr/french%20report%20dhumeaux.pdf. Accessed November 15, 2015.
27. Chao SD, Chang ET, Le PV, et al. The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. J Immigr Minor Health 2009; 11: 281-90.
28. Perumalswami PV, Factor SH, Kapelusznik L, et al. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol 2013; 58:890-7.
29. Médecins du Monde. Observatoire 2014 de l'accès aux droits et aux soins. Available at: http://wwwmedecinsdumondeorg/en-france/journeeinternationale-du-refus-de-la-misere-medecins-du-monde-publie-sonobservatoire-2014 Accessed November 15, 2015.
30. Agusti C, Fernandez-Lopez L, Mascort J, et al. Attitudes to rapid HIV testing among Spanish General Practitioners. HIV Med 2013; 14:53-6.
31. Poirier C, Aymeric S, Grammatico-Guillon L, et al. Rapid HIV test in family practice. Med Mal Infect 2015; 45:207-14.
32. Prost A, Griffiths CJ, Anderson J, et al. Feasibility and acceptability of offering rapid HIV tests to patients registering with primary care in London (United Kingdom): a pilot study. Sex Transm Infect 2009; 85:326-9.
33. Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. J Acquir Immune Defic Syndr 2005; 38:348-55.
34. Thornton AC, Delpech V, Kall MM, Nardone A. HIV testing in community settings in resource-rich countries: a systematic review of the evidence. HIV Med 2012; 13:416-26.
35. Hayes B, Briceno A, Asher A, et al. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs. BMC Public Health 2014; 14:645.
36. Morano JP, Zelenev A, Lombard A, et al. Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic. J Community Health 2014; 39:922-34.
37. Sullivan PS, Lansky A, Drake A. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. J Acquir Immune Defic Syndr 2004; 35:511-8.
38. Valdiserri RO, Moore M, Gerber AR, et al. A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep 1993; 108:12-8.
39. Fagard C, Champenois K, Joseph JP, et al. Feasibility of joint screening for HIV, HBV and HCV by general practitioners in two French counties, 2012 Bull Epidémiol Hebd 2014; 21-22:395-400.
40. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis 2013; 57:1164-71.
41. Powers KA, Miller WC. Building on the HIV cascade: a complementary "HIV states and transitions" framework for describing HIV diagnosis, care, and treatment at the population level. J Acquir Immune Defic Syndr 2015; 69:341-7.
42. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med 2013; 368:1859-61.
43. Hutchinson AB, Branson BM, Kim A, Farnham PG. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS 2006; 20:1597-604.
44. Pottie K, Medu O, Welch V, et al. Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review. BMJ Open 2014; 4:e006859.
45. Stockman LJ, Guilfoye SM, Benoit AL, et al. Rapid hepatitis C testing among persons at increased risk for infection Wisconsin, 2012-2013. MMWR Morb Mortal Wkly Rep 2014; 63:309-11.